Provided by Tiger Trade Technology Pte. Ltd.

Alpha Tau Medical

14.43
-0.0100-0.07%
Post-market: 14.680.2500+1.73%19:30 EDT
Volume:410.40K
Turnover:5.85M
Market Cap:1.33B
PE:-13.72
High:14.62
Open:14.49
Low:14.01
Close:14.44
52wk High:15.17
52wk Low:3.43
Shares:92.33M
Float Shares:63.79M
Volume Ratio:0.73
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0517
EPS(LYR):-0.5300
ROE:-141.68%
ROA:-25.71%
PB:30.24
PE(LYR):-27.23

Loading ...

Alpha Tau launches Italy feasibility study of Alpha DaRT in pancreatic cancer

Reuters
·
May 07

Alpha Tau to present Alpha DaRT-pembrolizumab head and neck cancer trial data at AHNS 2026

Reuters
·
May 05

Alpha Tau presents updated results from two clinical trials of Alpha DaRT

TIPRANKS
·
May 04

Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha Dart® Pancreatic Cancer Trials Presented at Ddw 2026

THOMSON REUTERS
·
May 04

Alpha Tau reports 100% local disease control in pooled Alpha DaRT pancreatic trials

Reuters
·
May 04

BRIEF-Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC Filing

Reuters
·
Apr 28

Alpha Tau files $300M mixed securities shelf

TIPRANKS
·
Apr 28

Alpha Tau Medical Ltd - May Sell up to $100 Mln Ordinary Shares Under Equity Distribution Agreement - SEC Filing

THOMSON REUTERS
·
Apr 28

Alpha Tau pancreatic cancer Alpha DaRT pooled data accepted for ASCO presentation

Reuters
·
Apr 27

Alpha Tau says FDA approves IDE supplement expanding pancreatic cancer IMPACT trial

Reuters
·
Apr 23

Alpha Tau Announces FDA Approval of Ide Supplement to Expand Alpha Dart® Impact Trial to Patients With Pancreatic Cancer Receiving Gemcitabine With Abraxane® (Nab-Paclitaxel)

THOMSON REUTERS
·
Apr 23

Alpha Tau Medical Ltd - Impact Trial Expanded to Recruit Total of 40 Patients

THOMSON REUTERS
·
Apr 23

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe With Alpha Dart® in French Multicenter Acapella Clinical Trial

THOMSON REUTERS
·
Apr 23

BRIEF-Alpha Tau Announces First-Ever Oral Presentation Of Alpha Dart® Pancreatic Cancer Data At Digestive Disease Week (Ddw) 2026

Reuters
·
Mar 31

Alpha Tau Medical Ltd. files initial beneficial ownership statement for Director Nadav Kidron

Reuters
·
Mar 19

Alpha Tau Medical Director Samuel Morry Blumenfeld Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Alpha Tau Medical Ltd. Director David Mark Milch Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Alpha Tau Medical Ltd. Director Maya Netser Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Alpha Tau Medical Ltd. files Form 3 initial beneficial ownership statement for CFO Raphi Levy

Reuters
·
Mar 19

Alpha Tau CFO Raphi Levy to present at Sidoti Virtual Small Cap Conference

Reuters
·
Mar 16